<VariationArchive VariationID="993689" VariationName="NM_017780.4(CHD7):c.1808_1811del (p.Asn603fs)" VariationType="Deletion" Accession="VCV000993689" Version="9" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2021-01-26" MostRecentSubmission="2022-01-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="981650" VariationID="993689">
      <GeneList>
        <Gene Symbol="CHD7" FullName="chromodomain helicase DNA binding protein 7" GeneID="55636" HGNC_ID="HGNC:20626" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>8q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60678740" stop="60868028" display_start="60678740" display_stop="60868028" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61591323" stop="61780586" display_start="61591323" display_stop="61780586" Strand="+" />
          </Location>
          <OMIM>608892</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC126860403" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr8:61693034-61694233" GeneID="126860403" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>8q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60780475" stop="60781674" display_start="60780475" display_stop="60781674" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_017780.4(CHD7):c.1808_1811del (p.Asn603fs)</Name>
      <CanonicalSPDI>NC_000008.11:60781139:AAACAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60781140" stop="60781143" display_start="60781140" display_stop="60781143" variantLength="4" positionVCF="60781139" referenceAlleleVCF="AAAAC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61693699" stop="61693702" display_start="61693699" display_stop="61693702" variantLength="4" positionVCF="61693698" referenceAlleleVCF="AAAAC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>N603fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.61693701_61693704del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.61693701_61693704del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.60781142_60781145del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.60781142_60781145del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007009.1" sequenceAccession="NG_007009" sequenceVersion="1" change="g.107363_107366del">
            <Expression>NG_007009.1:g.107363_107366del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017780.4" sequenceAccession="NM_017780" sequenceVersion="4" change="c.1808_1811del" MANESelect="true">
            <Expression>NM_017780.4:c.1808_1811del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060250.2" sequenceAccession="NP_060250" sequenceVersion="2" change="p.Asn603fs">
            <Expression>NP_060250.2:p.Asn603fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316690.1" sequenceAccession="NM_001316690" sequenceVersion="1" change="c.1716+92_1716+95del">
            <Expression>NM_001316690.1:c.1716+92_1716+95del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_176" sequenceAccession="LRG_176">
            <Expression>LRG_176:g.107363_107366del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1811203974" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017780.4(CHD7):c.1808_1811del (p.Asn603fs) AND not provided" Accession="RCV001812436" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_017780.4(CHD7):c.1808_1811del (p.Asn603fs) AND Hypogonadotropic hypogonadism 5 with or without anosmia" Accession="RCV001813821" Version="10">
        <ClassifiedConditionList TraitSetID="516">
          <ClassifiedCondition DB="MedGen" ID="C3552553">Hypogonadotropic hypogonadism 5 with or without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-05" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-01-26" MostRecentSubmission="2022-01-22">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="516" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5355" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome 5</ElementValue>
                <XRef ID="Kallmann+syndrome+5/8704" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="608892.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608892.0015" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPHIC HYPOGONADISM 5 WITHOUT ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="608892.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 5 with or without anosmia</ElementValue>
                <XRef ID="MONDO:0012880" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KAL5</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HH5</ElementValue>
                <XRef Type="MIM" ID="612370" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CHD7-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000558347" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000334133" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527475" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506067" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556729" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556733" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10773" />
                <XRef ID="10773" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CHD7-Related GnRH Deficiency (Kallmann Syndrome 5)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301296</ID>
                <ID Source="BookShelf">NBK1117</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="478" DB="Orphanet" />
              <XRef ID="C3552553" DB="MedGen" />
              <XRef ID="MONDO:0012880" DB="MONDO" />
              <XRef Type="MIM" ID="612370" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2899891" SubmissionDate="2020-12-11" DateLastUpdated="2021-01-26" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="2513444|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001471933" DateUpdated="2021-01-26" DateCreated="2021-01-26" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CHD7 c.1808_1811delACAA; p.Asn603fs variant is reported in the medical literature in at least one individual with atypical CHARGE syndrome (Lee 2009). This variant is also absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant causes a frameshift by deleting 4 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, several downstream truncating variants have been identified in individuals with CHARGE syndrome and are considered pathogenic (Bartels 2010, Janssen 2012). Based on available information, the c.1808_1811delACAA; p.Asn603fs variant is considered to be pathogenic. REFERENCES Bartels CF et al. Mutations in the CHD7 gene: the experience of a commercial laboratory. Genet Test Mol Biomarkers. 2010 Dec;14(6):881-91. Janssen N et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012 Aug;33(8):1149-60. Lee YW et al. Clinical and genetic analysis of the CHD7 gene in Korean patients with CHARGE syndrome. Clin Genet. 2009 Mar;75(3):290-3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.61693701_61693704delACAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2020 ARUP</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4040877" SubmissionDate="2022-01-18" DateLastUpdated="2022-01-22" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="NVEM2718|MedGen:C3552553" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002061248" DateUpdated="2022-01-22" DateCreated="2022-01-22" Type="SCV" Version="1" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1808_1811del;p.(Asn603Thrfs*4) is a null frameshift variant (NMD) in the CHD7 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevantexon to the transcript -PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 993689) - PS4_supporting. This variant is not present in population databases (rs1811203974, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. In summary, the currently available evidence indicates that the variant is pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_017780.4:exon 3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="1811203974" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017780.4:c.1808_1811del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3552553" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10963955</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4040877" TraitType="Disease" MappingType="XRef" MappingValue="C3552553" MappingRef="MedGen">
        <MedGen CUI="C3552553" Name="Hypogonadotropic hypogonadism 5 with or without anosmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2899891" TraitType="Finding" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

